1. Home
  2. VANI vs EQH Comparison

VANI vs EQH Comparison

Compare VANI & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VANI
  • EQH
  • Stock Information
  • Founded
  • VANI 1998
  • EQH 1859
  • Country
  • VANI United States
  • EQH United States
  • Employees
  • VANI N/A
  • EQH N/A
  • Industry
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • EQH Specialty Insurers
  • Sector
  • VANI Health Care
  • EQH Finance
  • Exchange
  • VANI Nasdaq
  • EQH Nasdaq
  • Market Cap
  • VANI 75.8M
  • EQH 16.2B
  • IPO Year
  • VANI 2014
  • EQH N/A
  • Fundamental
  • Price
  • VANI $1.21
  • EQH $52.80
  • Analyst Decision
  • VANI Strong Buy
  • EQH Buy
  • Analyst Count
  • VANI 1
  • EQH 11
  • Target Price
  • VANI $4.00
  • EQH $64.55
  • AVG Volume (30 Days)
  • VANI 52.1K
  • EQH 2.7M
  • Earning Date
  • VANI 11-12-2025
  • EQH 11-03-2025
  • Dividend Yield
  • VANI N/A
  • EQH 2.05%
  • EPS Growth
  • VANI N/A
  • EQH N/A
  • EPS
  • VANI N/A
  • EQH 1.38
  • Revenue
  • VANI N/A
  • EQH $13,960,000,000.00
  • Revenue This Year
  • VANI N/A
  • EQH $17.36
  • Revenue Next Year
  • VANI N/A
  • EQH $1.25
  • P/E Ratio
  • VANI N/A
  • EQH $38.17
  • Revenue Growth
  • VANI N/A
  • EQH 21.29
  • 52 Week Low
  • VANI $0.91
  • EQH $40.38
  • 52 Week High
  • VANI $1.80
  • EQH $56.61
  • Technical
  • Relative Strength Index (RSI)
  • VANI 45.27
  • EQH 47.94
  • Support Level
  • VANI $1.19
  • EQH $52.40
  • Resistance Level
  • VANI $1.33
  • EQH $54.43
  • Average True Range (ATR)
  • VANI 0.08
  • EQH 1.12
  • MACD
  • VANI 0.01
  • EQH -0.03
  • Stochastic Oscillator
  • VANI 26.92
  • EQH 43.56

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.

Share on Social Networks: